Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kornegay CJ"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hwang CS; University of Washington School of Medicine, Seattle.; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Division of Epidemiology, US Food and Drug Administration, Silver Spring, Maryland., Kang EM; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Division of Epidemiology, US Food and Drug Administration, Silver Spring, Maryland.; Now with Chiltern International Inc, King of Prussia, Pennsylvania., Ding Y; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Division of Epidemiology, US Food and Drug Administration, Silver Spring, Maryland., Ocran-Appiah J; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Division of Epidemiology, US Food and Drug Administration, Silver Spring, Maryland.; Now with GlaxoSmithKline, Rockville, Maryland., McAninch JK; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Division of Epidemiology, US Food and Drug Administration, Silver Spring, Maryland., Staffa JA; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Division of Epidemiology, US Food and Drug Administration, Silver Spring, Maryland., Kornegay CJ; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Division of Epidemiology, US Food and Drug Administration, Silver Spring, Maryland., Meyer TE; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Division of Epidemiology, US Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
JAMA network open [JAMA Netw Open] 2018 Jun 01; Vol. 1 (2), pp. e180216. Date of Electronic Publication: 2018 Jun 01.
Autor:
By K; US Food and Drug Administration, Silver Spring, MD, USA., McAninch JK; US Food and Drug Administration, Silver Spring, MD, USA., Keeton SL; US Food and Drug Administration, Silver Spring, MD, USA., Secora A; US Food and Drug Administration, Silver Spring, MD, USA., Kornegay CJ; US Food and Drug Administration, Silver Spring, MD, USA., Hwang CS; US Food and Drug Administration, Silver Spring, MD, USA., Ly T; US Food and Drug Administration, Silver Spring, MD, USA., Levenson MS; US Food and Drug Administration, Silver Spring, MD, USA.
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2018 May; Vol. 27 (5), pp. 473-478. Date of Electronic Publication: 2017 Aug 23.
Autor:
Hwang CS; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Kang EM; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Kornegay CJ; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Staffa JA; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Jones CM; Division of Science Policy, Office of the Assistant Secretary for Planning and Evaluation, U.S. Department of Health and Human Services, Washington, D.C., McAninch JK; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. Electronic address: jana.mcaninch@fda.hhs.gov.
Publikováno v:
American journal of preventive medicine [Am J Prev Med] 2016 Aug; Vol. 51 (2), pp. 151-160. Date of Electronic Publication: 2016 Apr 11.
Autor:
Johnson ES; The Center for Health Research, Kaiser Permanente, Portland, Oregon, USA. Eric.S.Johnson@kpchr.org, Bartman BA, Briesacher BA, Fleming NS, Gerhard T, Kornegay CJ, Nourjah P, Sauer B, Schumock GT, Sedrakyan A, Stürmer T, West SL, Schneeweiss S
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2013 Jan; Vol. 22 (1), pp. 1-6. Date of Electronic Publication: 2012 Oct 01.
Autor:
Hammad TA; Office of Surveillance and Epidemiology, Food and Drug Administration, Silver Spring, MD 20993-0002, USA. tarek.hammad@fda.hhs.gov, Graham DJ, Staffa JA, Kornegay CJ, Dal Pan GJ
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2008 Apr; Vol. 17 (4), pp. 315-21.